Sami Corwin
Stock Analyst at William Blair
(n/a)
# 4,407
Out of 4,414 analysts
4
Total ratings
n/a
Success rate
-28.14%
Average return
Main Sectors:
Top Industries:
4 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NGNE Neurogene | Initiates: Outperform | n/a | $33.77 | - | 1 | Mar 21, 2024 | |
| MESO Mesoblast | Downgrades: Market Perform | n/a | $7.21 | - | 1 | Aug 4, 2023 | |
| CRSP CRISPR Therapeutics AG | Reinstates: Outperform | $75 | $53.81 | +39.38% | 1 | May 30, 2023 | |
| LEGN Legend Biotech | Initiates: Market Perform | n/a | $43.98 | - | 1 | May 25, 2023 |
Neurogene
Mar 21, 2024
Initiates: Outperform
Price Target: n/a
Current: $33.77
Upside: -
Mesoblast
Aug 4, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $7.21
Upside: -
CRISPR Therapeutics AG
May 30, 2023
Reinstates: Outperform
Price Target: $75
Current: $53.81
Upside: +39.38%
Legend Biotech
May 25, 2023
Initiates: Market Perform
Price Target: n/a
Current: $43.98
Upside: -